Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
GS-9876, A NOVEL, HIGHLY SELECTIVE, SYK INHIBITOR IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY Kivitz, A., Mehta, D., Matzkies, F., Mozaffarian, A., Kunder, R., Di Paolo, J. A., Mozaffarian, N., Hsueh, S., Kim, J., Jiang, W., Liu, L., Sundy, J., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 746–47
View details for DOI 10.1136/annrheumdis-2019-eular.2144
View details for Web of Science ID 000472207102193